CPIC (2601 HK) - Life OPAT Outperformed; 2Q Earnings and NAV Returned to a Healthy Trend
CPIC’s 2Q earnings strengthened. Group/Life OPAT was up 7.1%/5% like-for-like (LFL) to RMB 19.9bn/15bn, suggesting a sequential uptick in 2Q25 vs....
184 Views
CPIC (2601 HK) - Participating Sales Noticeably Increased; MTM Losses Dragged a Profit Miss in 1Q25
CPIC reported 1Q25 results with strong NBV up 39% like-for-like, a beat to our expectation, yet net profit down 18.1% YoY as a miss. Net asset...
270 Views
CPIC (2601 HK) - Life OPAT Beat, Driving DPS to Rise Faster than Group OPAT
CPIC reported a beat on Life OPAT, NBV growth and CSM, indicating the insurer’s strong capability to capitalize on value growth and effective A/L...
216 Views
China Insurance - 11/12M Monthly: Life Sales Diverged During the Jumpstart
Life growth diverged in Dec among listed peers, yet the market trends weakened overall in Nov-Dec, due to eased momentum of 2025 jumpstart sales.
266 Views
China Insurance - Life Premium Retreated as Expected, P&C Grew with Auto Sales Momentum
Life premium growth eased in Oct as expected, due to the release of front-loaded demands in Jul/Aug prior to the PIR cut, which dragged the rise of...
325 Views